Additional file 4 of In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy

21 unique contact patterns derived from the 32 structures listed in Table S3 (see Additional File 3). Each of the 9 peptide positions was evaluated for contact with the T-cell receptor/ Antigen binding domain of the antibody in each of the 32 complexes. A cross symbol means that the residue at the peptide position is not in contact. (TIF 1023 kb)